<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html><head><meta http-equiv="content-type" content="text/html; charset=utf-8"/><meta name="viewport" content="width=device-width, initial-scale=0.8"/><title>Cardiovasculaire et Strategies anti-infectieuses</title><link rel="stylesheet" type="text/css" href="scribble.css" title="default"/><link rel="stylesheet" type="text/css" href="manual-style.css" title="default"/><link rel="stylesheet" type="text/css" href="manual-racket.css" title="default"/><script type="text/javascript" src="scribble-common.js"></script><script type="text/javascript" src="manual-racket.js"></script><!--[if IE 6]><style type="text/css">.SIEHidden { overflow: hidden; }</style><![endif]--></head><body id="scribble-racket-lang-org"><div class="tocset"><div class="tocview"><div class="tocviewlist tocviewlisttopspace"><div class="tocviewtitle"><table cellspacing="0" cellpadding="0"><tr><td style="width: 1em;"><a href="javascript:void(0);" title="Expand/Collapse" class="tocviewtoggle" onclick="TocviewToggle(this,&quot;tocview_0&quot;);">&#9658;</a></td><td></td><td><a href="" class="tocviewselflink" data-pltdoc="x">Cardiovasculaire et Strategies anti-<wbr></wbr>infectieuses</a></td></tr></table></div><div class="tocviewsublistonly" style="display: none;" id="tocview_0"><table cellspacing="0" cellpadding="0"><tr><td align="right">1&nbsp;</td><td><a href="#%28part._.Antifongiques%29" class="tocviewlink" data-pltdoc="x">Antifongiques</a></td></tr><tr><td align="right">2&nbsp;</td><td><a href="#%28part._.Antihypertenseurs%29" class="tocviewlink" data-pltdoc="x">Antihypertenseurs</a></td></tr><tr><td align="right">3&nbsp;</td><td><a href="#%28part._.Hypolipemiants%29" class="tocviewlink" data-pltdoc="x">Hypolipemiants</a></td></tr><tr><td align="right">4&nbsp;</td><td><a href="#%28part._antitum%29" class="tocviewlink" data-pltdoc="x">Antitumoraux</a></td></tr><tr><td align="right">5&nbsp;</td><td><a href="#%28part._ksein%29" class="tocviewlink" data-pltdoc="x">traitement hormonologique du cancer du sein</a></td></tr><tr><td align="right">6&nbsp;</td><td><a href="#%28part._.Agents_alkylants%29" class="tocviewlink" data-pltdoc="x">Agents alkylants</a></td></tr></table></div></div></div><div class="tocsub"><table class="tocsublist" cellspacing="0"><tr><td><span class="tocsublinknumber"></span><a href="#%28part._.Cardiovasculaire_et_.Strategies_anti-infectieuses%29" class="tocsubseclink" data-pltdoc="x">Cardiovasculaire et Strategies anti-<wbr></wbr>infectieuses</a></td></tr><tr><td><span class="tocsublinknumber">1<tt>&nbsp;</tt></span><a href="#%28part._.Antifongiques%29" class="tocsubseclink" data-pltdoc="x">Antifongiques</a></td></tr><tr><td><span class="tocsublinknumber">1.1<tt>&nbsp;</tt></span><a href="#%28part._.Mycoses_superficielles%29" class="tocsubseclink" data-pltdoc="x">Mycoses superficielles</a></td></tr><tr><td><span class="tocsublinknumber">1.2<tt>&nbsp;</tt></span><a href="#%28part._.Antifongiques_d_origine_biologique%29" class="tocsubseclink" data-pltdoc="x">Antifongiques <span style="font-style: italic">d&rsquo;origine biologique</span></a></td></tr><tr><td><span class="tocsublinknumber">1.2.1<tt>&nbsp;</tt></span><a href="#%28part._polyenes%29" class="tocsubseclink" data-pltdoc="x">Polyenes</a></td></tr><tr><td><span class="tocsublinknumber">1.2.2<tt>&nbsp;</tt></span><a href="#%28part._griseofulvin%29" class="tocsubseclink" data-pltdoc="x">Griseofulvine</a></td></tr><tr><td><span class="tocsublinknumber">2<tt>&nbsp;</tt></span><a href="#%28part._.Antihypertenseurs%29" class="tocsubseclink" data-pltdoc="x">Antihypertenseurs</a></td></tr><tr><td><span class="tocsublinknumber">2.1<tt>&nbsp;</tt></span><a href="#%28part._sartans%29" class="tocsubseclink" data-pltdoc="x">Sartans</a></td></tr><tr><td><span class="tocsublinknumber">2.2<tt>&nbsp;</tt></span><a href="#%28part._iec%29" class="tocsubseclink" data-pltdoc="x">Inhibiteurs de l&rsquo;enzyme de conversion</a></td></tr><tr><td><span class="tocsublinknumber">3<tt>&nbsp;</tt></span><a href="#%28part._.Hypolipemiants%29" class="tocsubseclink" data-pltdoc="x">Hypolipemiants</a></td></tr><tr><td><span class="tocsublinknumber">3.1<tt>&nbsp;</tt></span><a href="#%28part._.Statines%29" class="tocsubseclink" data-pltdoc="x">Statines</a></td></tr><tr><td><span class="tocsublinknumber">3.1.1<tt>&nbsp;</tt></span><a href="#%28part.__.Statines_d_origine_hemisynthetique_%29" class="tocsubseclink" data-pltdoc="x"> Statines d&rsquo;origine hemisynthetique </a></td></tr><tr><td><span class="tocsublinknumber">3.1.2<tt>&nbsp;</tt></span><a href="#%28part.__.Statines_d_origine_synthetique_%29" class="tocsubseclink" data-pltdoc="x"> Statines d&rsquo;origine synthetique </a></td></tr><tr><td><span class="tocsublinknumber">4<tt>&nbsp;</tt></span><a href="#%28part._antitum%29" class="tocsubseclink" data-pltdoc="x">Antitumoraux</a></td></tr><tr><td><span class="tocsublinknumber">4.1<tt>&nbsp;</tt></span><a href="#%28part._.Le_protocole_de_chimioth_rapie%29" class="tocsubseclink" data-pltdoc="x">Le protocole de chimioth&#233;rapie</a></td></tr><tr><td><span class="tocsublinknumber">4.2<tt>&nbsp;</tt></span><a href="#%28part._antitum._tox._gen%29" class="tocsubseclink" data-pltdoc="x">Toxicit&#233; G&#233;n&#233;rale</a></td></tr><tr><td><span class="tocsublinknumber">4.3<tt>&nbsp;</tt></span><a href="#%28part._antitum._resistance%29" class="tocsubseclink" data-pltdoc="x">R&#233;sistance</a></td></tr><tr><td><span class="tocsublinknumber">4.4<tt>&nbsp;</tt></span><a href="#%28part._.Cytotoxiques_issus_des_plantes_sup_rieures%29" class="tocsubseclink" data-pltdoc="x">Cytotoxiques issus des
<span class="emph">plantes sup&#233;rieures</span></a></td></tr><tr><td><span class="tocsublinknumber">4.4.1<tt>&nbsp;</tt></span><a href="#%28part._.Agents_intercalants%29" class="tocsubseclink" data-pltdoc="x">Agents intercalants</a></td></tr><tr><td><span class="tocsublinknumber">4.4.2<tt>&nbsp;</tt></span><a href="#%28part._.Poisons_du_fuseau%29" class="tocsubseclink" data-pltdoc="x">Poisons du fuseau</a></td></tr><tr><td><span class="tocsublinknumber">4.4.3<tt>&nbsp;</tt></span><a href="#%28part._.Inhibiteurs_des_.Topoisom_rases%29" class="tocsubseclink" data-pltdoc="x">Inhibiteurs des Topoisom&#233;rases</a></td></tr><tr><td><span class="tocsublinknumber">5<tt>&nbsp;</tt></span><a href="#%28part._ksein%29" class="tocsubseclink" data-pltdoc="x">traitement hormonologique du cancer du sein</a></td></tr><tr><td><span class="tocsublinknumber">5.1<tt>&nbsp;</tt></span><a href="#%28part._.Castration_physique_d_finitive%29" class="tocsubseclink" data-pltdoc="x">Castration physique <span class="emph">d&#233;finitive</span></a></td></tr><tr><td><span class="tocsublinknumber">5.2<tt>&nbsp;</tt></span><a href="#%28part._.Castration_chimique__temporaire_et_r_versible%29" class="tocsubseclink" data-pltdoc="x">Castration chimique, <span class="emph">temporaire et r&#233;versible</span></a></td></tr><tr><td><span class="tocsublinknumber">6<tt>&nbsp;</tt></span><a href="#%28part._.Agents_alkylants%29" class="tocsubseclink" data-pltdoc="x">Agents alkylants</a></td></tr><tr><td><span class="tocsublinknumber">6.1<tt>&nbsp;</tt></span><a href="#%28part._moutardes%29" class="tocsubseclink" data-pltdoc="x">Moutardes Azot&#233;es</a></td></tr></table></div></div><div class="maincolumn"><div class="main"><div class="versionbox"><span class="versionNoNav">7.9</span></div><h2><a name="(part._.Cardiovasculaire_et_.Strategies_anti-infectieuses)"></a>Cardiovasculaire et Strategies anti-infectieuses</h2><div class="SAuthorListBox"><span class="SAuthorList"><p class="author">Youssef Sahli</p></span></div><blockquote class="refpara"><blockquote class="refcolumn"><blockquote class="refcontent"><p><span style="font-weight: bold">14 janvier 13h</span>:
 <br/>
Strategie anti infectieuse
Cardiovasculaire
<br/>
<span style="font-style: italic">Auditorium</span></p></blockquote></blockquote></blockquote><table cellspacing="0" cellpadding="0"><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._.Antifongiques%29" class="toptoclink" data-pltdoc="x">1<span class="hspace">&nbsp;</span>Antifongiques</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._.Mycoses_superficielles%29" class="toclink" data-pltdoc="x">1.1<span class="hspace">&nbsp;</span>Mycoses superficielles</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._.Antifongiques_d_origine_biologique%29" class="toclink" data-pltdoc="x">1.2<span class="hspace">&nbsp;</span>Antifongiques <span style="font-style: italic">d&rsquo;origine biologique</span></a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._polyenes%29" class="toclink" data-pltdoc="x">1.2.1<span class="hspace">&nbsp;</span>Polyenes</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._griseofulvin%29" class="toclink" data-pltdoc="x">1.2.2<span class="hspace">&nbsp;</span>Griseofulvine</a></p></td></tr><tr><td><p><span class="hspace"></span></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._.Antihypertenseurs%29" class="toptoclink" data-pltdoc="x">2<span class="hspace">&nbsp;</span>Antihypertenseurs</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._sartans%29" class="toclink" data-pltdoc="x">2.1<span class="hspace">&nbsp;</span>Sartans</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._iec%29" class="toclink" data-pltdoc="x">2.2<span class="hspace">&nbsp;</span>Inhibiteurs de l&rsquo;enzyme de conversion</a></p></td></tr><tr><td><p><span class="hspace"></span></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._.Hypolipemiants%29" class="toptoclink" data-pltdoc="x">3<span class="hspace">&nbsp;</span>Hypolipemiants</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._.Statines%29" class="toclink" data-pltdoc="x">3.1<span class="hspace">&nbsp;</span>Statines</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part.__.Statines_d_origine_hemisynthetique_%29" class="toclink" data-pltdoc="x">3.1.1<span class="hspace">&nbsp;</span> Statines d&rsquo;origine hemisynthetique </a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part.__.Statines_d_origine_synthetique_%29" class="toclink" data-pltdoc="x">3.1.2<span class="hspace">&nbsp;</span> Statines d&rsquo;origine synthetique </a></p></td></tr><tr><td><p><span class="hspace"></span></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._antitum%29" class="toptoclink" data-pltdoc="x">4<span class="hspace">&nbsp;</span>Antitumoraux</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._.Le_protocole_de_chimioth_rapie%29" class="toclink" data-pltdoc="x">4.1<span class="hspace">&nbsp;</span>Le protocole de chimioth&#233;rapie</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._antitum._tox._gen%29" class="toclink" data-pltdoc="x">4.2<span class="hspace">&nbsp;</span>Toxicit&#233; G&#233;n&#233;rale</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._antitum._resistance%29" class="toclink" data-pltdoc="x">4.3<span class="hspace">&nbsp;</span>R&#233;sistance</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._.Cytotoxiques_issus_des_plantes_sup_rieures%29" class="toclink" data-pltdoc="x">4.4<span class="hspace">&nbsp;</span>Cytotoxiques issus des
<span class="emph">plantes sup&#233;rieures</span></a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._.Agents_intercalants%29" class="toclink" data-pltdoc="x">4.4.1<span class="hspace">&nbsp;</span>Agents intercalants</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._.Poisons_du_fuseau%29" class="toclink" data-pltdoc="x">4.4.2<span class="hspace">&nbsp;</span>Poisons du fuseau</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._.Inhibiteurs_des_.Topoisom_rases%29" class="toclink" data-pltdoc="x">4.4.3<span class="hspace">&nbsp;</span>Inhibiteurs des Topoisom&#233;rases</a></p></td></tr><tr><td><p><span class="hspace"></span></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._ksein%29" class="toptoclink" data-pltdoc="x">5<span class="hspace">&nbsp;</span>traitement hormonologique du cancer du sein</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._.Castration_physique_d_finitive%29" class="toclink" data-pltdoc="x">5.1<span class="hspace">&nbsp;</span>Castration physique <span class="emph">d&#233;finitive</span></a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._.Castration_chimique__temporaire_et_r_versible%29" class="toclink" data-pltdoc="x">5.2<span class="hspace">&nbsp;</span>Castration chimique, <span class="emph">temporaire et r&#233;versible</span></a></p></td></tr><tr><td><p><span class="hspace"></span></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._.Agents_alkylants%29" class="toptoclink" data-pltdoc="x">6<span class="hspace">&nbsp;</span>Agents alkylants</a></p></td></tr><tr><td><p><span class="hspace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><a href="#%28part._moutardes%29" class="toclink" data-pltdoc="x">6.1<span class="hspace">&nbsp;</span>Moutardes Azot&#233;es</a></p></td></tr></table><h3>1<tt>&nbsp;</tt><a name="(part._.Antifongiques)"></a>Antifongiques</h3><p><img src="overview.jpeg" alt=""/></p><h4>1.1<tt>&nbsp;</tt><a name="(part._.Mycoses_superficielles)"></a>Mycoses superficielles</h4><p><div class="SIntrapara"><blockquote class="refpara"><blockquote class="refcolumn"><blockquote class="refcontent"><p><div class="SIntrapara"><img src="trichophyton.jpeg" alt=""/>
</div><div class="SIntrapara"><blockquote class="SCentered"><p><span style="font-style: italic">Trichophyton</span></p></blockquote></div></p></blockquote></blockquote></blockquote></div><div class="SIntrapara"><table cellspacing="0" cellpadding="0" class="boxed" style="border-collapse: collapse;"><tr><td align="center" style="border-bottom: 1px solid black;"><p><span style="font-weight: bold">Dermatophyties</span></p></td><td align="center" style="border-bottom: 1px solid black;"><p></p></td><td align="center" style="border-bottom: 1px solid black;"><p><span style="font-weight: bold">Pytirosporoses</span></p></td><td align="center" style="border-bottom: 1px solid black;"><p></p></td><td align="center" style="border-bottom: 1px solid black;"><p><span style="font-weight: bold">Candidoses</span></p></td></tr><tr><td align="center"><p>Epidermophyton</p></td><td align="center"><p></p></td><td align="center"><p>Malassezia furfur</p></td><td align="center"><p></p></td><td align="center"><p>Candida sp</p></td></tr><tr><td align="center"><p>Microsporum</p></td><td align="center"><p></p></td><td align="center"><p>Ptyrosporum ovale</p></td><td align="center"><p></p></td><td align="center"><p></p></td></tr><tr><td align="center"><p>Teignes</p></td><td align="center"><p></p></td><td align="center"><p>Pytiriasis versicolor</p></td><td align="center"><p></p></td><td align="center"><p>muguet, perleche</p></td></tr><tr><td align="center"><p>Herpes circine</p></td><td align="center"><p></p></td><td align="center"><p>Dermite sebhorreique</p></td><td align="center"><p></p></td><td align="center"><p>Balanite, vulvovaginite</p></td></tr><tr><td align="center"><p><span style="font-style: italic">Acide undecylenique</span></p></td><td align="center"><p></p></td><td align="center"><p><span style="font-style: italic">Sulfure de selenium SELSUN</span></p></td><td align="center"><p></p></td><td align="center"><p></p></td></tr></table></div></p><h4>1.2<tt>&nbsp;</tt><a name="(part._.Antifongiques_d_origine_biologique)"></a>Antifongiques <span style="font-style: italic">d&rsquo;origine biologique</span></h4><h5>1.2.1<tt>&nbsp;</tt><a name="(part._polyenes)"></a>Polyenes</h5><p><img src="amphotericin.png" alt="Amphotericin B" width="280" height="142"/></p><h5>1.2.2<tt>&nbsp;</tt><a name="(part._griseofulvin)"></a>Griseofulvine</h5><p>Elle est derivee du Benzodihydrofurane
C&rsquo;est un poison du fuseau actif sur tous les dermatophytes</p><p><div class="SIntrapara"><span style="font-weight: bold">Mecanisme d&rsquo;action</span>
</div><div class="SIntrapara"><ul><li><p>Inhibition de la synthese des acides nucleiques</p></li><li><p>inhibition de la synth de la paroi fongique</p></li><li><p>Blocage de la mitose</p></li><li><p>Perturbation du trp du cytoplasme vers la peripherie</p></li></ul></div><div class="SIntrapara"><span style="font-weight: bold">Effets indesirables</span>
<span style="font-style: italic">Bien toleree generalement</span>
</div><div class="SIntrapara"><ul><li><p>Cephalees</p></li><li><p>Vertiges</p></li><li><p>Confusion</p></li><li><p>Nausees, vomissements</p></li><li><p>effets cutanes et photosensibilisation</p></li></ul></div></p><p><div class="SIntrapara"><span style="font-weight: bold">Interactions medicamenteuses</span>
</div><div class="SIntrapara"><ul><li><p>Deconseillee avec les oestroprogestatifs</p></li><li><p>Effet antabuse avec l&rsquo;alcool</p></li></ul></div></p><p><div class="SIntrapara"><span style="font-weight: bold">Indications</span>
</div><div class="SIntrapara"><ul><li><p>Teignes</p></li><li><p>Dermatophytoses</p></li><li><p>Herp&#232;s circin&#233;</p></li></ul></div></p><h3>2<tt>&nbsp;</tt><a name="(part._.Antihypertenseurs)"></a>Antihypertenseurs</h3><h4>2.1<tt>&nbsp;</tt><a name="(part._sartans)"></a>Sartans</h4><p>Antagonistes competitifs reversibles des recepteurs a
l&rsquo;angiotensine II <span style="font-style: italic">R.AT1</span></p><p><table cellspacing="0" cellpadding="0" class="boxed" style="border-collapse: collapse;"><tr><td valign="center" style="border-bottom: 1px solid black;; border-left: 1px solid black;"><p><span style="font-weight: bold">AT1</span></p></td><td valign="center" style="border-bottom: 1px solid black;; border-right: 1px solid black;"><p><span style="font-weight: bold">AT2</span></p></td></tr><tr><td valign="center" style="border-bottom: 1px solid black;; border-left: 1px solid black;"><p>Vasoconstriction</p></td><td valign="center" style="border-bottom: 1px solid black;; border-right: 1px solid black;"><p>Vasodilatation</p></td></tr><tr><td valign="center" style="border-bottom: 1px solid black;; border-left: 1px solid black;"><p>Vasotrophique</p></td><td valign="center" style="border-bottom: 1px solid black;; border-right: 1px solid black;"><p>anti-trophique</p></td></tr><tr><td valign="center" style="border-bottom: 1px solid black;; border-left: 1px solid black;"><p>Reabsorption Na H2O</p></td><td valign="center" style="border-bottom: 1px solid black;; border-right: 1px solid black;"><p>Natriurese</p></td></tr></table></p><p><div class="SIntrapara"><span style="font-weight: bold">Pharmacocin&#233;tique</span>
</div><div class="SIntrapara"><ul><li><p>Resorption digestive bonne</p></li><li><p>1er passage hepatique fort avec un m&#233;tabolite actif</p></li><li><p>LPP forte</p></li><li><p>Elimination urinaire et biliaire (mixte)</p></li></ul></div></p><p><div class="SIntrapara"><span style="font-weight: bold">Indications</span>
</div><div class="SIntrapara"><ul><li><p>Candesartan: <a href="https://www.icm-mhi.org/fr/soins-et-services/maladies-cardiovasculaires/insuffisance-cardiaque">Insuffisance cardiaque</a></p></li></ul></div></p><p><div class="SIntrapara"><span style="font-weight: bold">Effets ind&#233;sirables</span>
</div><div class="SIntrapara"><ul><li><p>Hypotension dose-d&#233;pendante</p></li><li><p>D&#233;terioration de la fonction r&#233;nale</p></li><li><p>Hyperkaliemie, Hyperuricemie</p></li><li><p>Angioed&#232;me</p></li></ul></div></p><p><div class="SIntrapara"><span style="font-weight: bold">Contre-indication</span>
<br/>
<span style="font-weight: bold"><span style="font-style: italic">Absolue</span></span>
</div><div class="SIntrapara"><ul><li><p>Grossesse</p></li><li><p>Association avec les diur&#233;tiques dans les cas d&rsquo;insuffisance r&#233;nale s&#233;v&#232;re.</p></li></ul></div></p><p><div class="SIntrapara"><span style="font-style: italic">Leur efficacit&#233; est <a href="http://www.chups.jussieu.fr/polys/pharmaco/poly/POLY.Chp.9.3.html">amoindrie par les AINS</a>.</span>
<br/>
</div><div class="SIntrapara"><span style="font-weight: bold"><span style="font-style: italic">Relative</span></span>
<br/>
<a href="https://fr.wikipedia.org/wiki/St%C3%A9nose"> Stenose</a>
bilaterale des arteres renales</div></p><h4>2.2<tt>&nbsp;</tt><a name="(part._iec)"></a>Inhibiteurs de l&rsquo;enzyme de conversion</h4><p><span style="font-weight: bold">M&#233;canisme d&rsquo;action</span>
<a href="http://www.chups.jussieu.fr/polys/pharmaco/poly/POLY.Chp.9.3.html">Inhibiteurs de la synthese d&rsquo;angiotensine II</a>
La cascade enzymatique est inhib&#233;e,
de la <span style="font-style: italic">synth&#232;se</span> d&rsquo;aldost&#233;rone &#224; la <span style="font-style: italic">d&#233;gradation</span> des bradykinines.</p><p><div class="SIntrapara"><span style="font-weight: bold">Indications</span>
</div><div class="SIntrapara"><ul><li><p>Hypertension art&#233;rielle</p></li><li><p>insuffisance cardiaque</p></li><li><p>infarctus du myocarde</p></li></ul></div><div class="SIntrapara">Leur efficacit&#233; antihypertensive est comparable &#224; celle des autres grandes
cat&#233;gories d&rsquo;antihypertenseurs.</div></p><h3>3<tt>&nbsp;</tt><a name="(part._.Hypolipemiants)"></a>Hypolipemiants</h3><h4>3.1<tt>&nbsp;</tt><a name="(part._.Statines)"></a>Statines</h4><h5>3.1.1<tt>&nbsp;</tt><a name="(part.__.Statines_d_origine_hemisynthetique_)"></a> Statines d&rsquo;origine hemisynthetique </h5><ul><li><p>Simvastatine ZOCOR </p></li><li><p>Pravastatine ELISOR</p></li></ul><h5>3.1.2<tt>&nbsp;</tt><a name="(part.__.Statines_d_origine_synthetique_)"></a> Statines d&rsquo;origine synthetique </h5><ul><li><p>Fluvastatine FRACTAL</p></li><li><p>Rosuvastatine CRESTOR</p></li><li><p>Atorvastatine TAHOR</p></li></ul><h3>4<tt>&nbsp;</tt><a name="(part._antitum)"></a>Antitumoraux</h3><h4>4.1<tt>&nbsp;</tt><a name="(part._.Le_protocole_de_chimioth_rapie)"></a>Le protocole de chimioth&#233;rapie</h4><p><div class="SIntrapara">On utilise une monoth&#233;rapie pour la premi&#232;re chimioth&#233;rapie.
La polyth&#233;rapie permet d&rsquo;avoir ensuite un effet synergique entre les diff&#233;rents agents.
</div><div class="SIntrapara"><ul><li><p>Agent recrutant</p></li><li><p>Agent synchronisant</p></li><li><p>Agent phase-d&#233;pendant</p></li></ul></div></p><h4>4.2<tt>&nbsp;</tt><a name="(part._antitum._tox._gen)"></a>Toxicit&#233; G&#233;n&#233;rale</h4><ul><li><p>My&#233;losuppression</p></li><li><p>Insuffisance testiculaire et ovarienne</p></li><li><p>Alop&#233;cie</p></li></ul><h4>4.3<tt>&nbsp;</tt><a name="(part._antitum._resistance)"></a>R&#233;sistance</h4><ul><li><p><span style="font-style: italic">Surexpression des cellules tumorales de syst&#232;mes physiologiques de r&#233;sistance au stress oxydatif</span></p></li><li><p>Pompes <a href="https://www.em-consulte.com/article/28679/pompes-d-efflux-et-resistance-aux-antibiotiques-ch"><span style="font-style: italic">Multi Drug Resistant</span></a> &#224; reflux</p></li><li><p>Enzymes favorisant la d&#233;toxification cellulaire</p></li><li><p>Mutation des enzymes impliqu&#233;es dans la r&#233;paration des l&#233;sions de l&rsquo;ADN: Elles &#233;chappent &#224; l&rsquo;inhibition du x&#233;nobiotique.</p></li></ul><h4>4.4<tt>&nbsp;</tt><a name="(part._.Cytotoxiques_issus_des_plantes_sup_rieures)"></a>Cytotoxiques issus des
<span class="emph">plantes sup&#233;rieures</span></h4><h5>4.4.1<tt>&nbsp;</tt><a name="(part._.Agents_intercalants)"></a>Agents intercalants</h5><p><span style="font-weight: bold">M&#233;canisme</span>: Forment une double h&#233;lice d&rsquo;ADN et entra&#238;nent une
d&#233;spiralisation bloquant la transcription et la duplication.
Ils bloquent le site actif de la <span style="font-weight: bold">CK2</span>.
Ils inhibent l&rsquo;action de la <span class="emph">Topoisom&#233;rase II</span></p><p><span style="font-weight: bold">Botanique</span>:
 Plantes proches de l&rsquo;<span class="emph">Ellipticine</span></p><p><span style="font-weight: bold">Mol&#233;cules</span>:
 <span class="emph">Ac&#233;tate d&rsquo;elliptinium CELIPTIUM</span></p><h5>4.4.2<tt>&nbsp;</tt><a name="(part._.Poisons_du_fuseau)"></a>Poisons du fuseau</h5><ul><li><p>Vinca-alcalo&#239;des</p></li><li><p>Taxanes</p></li></ul><h5>4.4.3<tt>&nbsp;</tt><a name="(part._.Inhibiteurs_des_.Topoisom_rases)"></a>Inhibiteurs des Topoisom&#233;rases</h5><ul><li><p>H&#233;t&#233;rosides lactoniques</p></li><li><p>Alcalo&#239;des de la camptot&#233;cine</p></li></ul><h3>5<tt>&nbsp;</tt><a name="(part._ksein)"></a>traitement hormonologique du cancer du sein</h3><h4>5.1<tt>&nbsp;</tt><a name="(part._.Castration_physique_d_finitive)"></a>Castration physique <span class="emph">d&#233;finitive</span></h4><p>Elle se fait par chirurgie et radiotherapie localis&#233;e.</p><h4>5.2<tt>&nbsp;</tt><a name="(part._.Castration_chimique__temporaire_et_r_versible)"></a>Castration chimique, <span class="emph">temporaire et r&#233;versible</span></h4><p><div class="SIntrapara">Blocage de l&rsquo;axe hypothalamo-hypophyso-gonadique pour emp&#234;cher la s&#233;cr&#233;tion hormonale</div><div class="SIntrapara"><ul><li><p>Analogues GnRH</p></li><li><p><div class="SIntrapara">Progestatifs
</div><div class="SIntrapara"><ul><li><p>M&#233;droxyprogest&#233;rone DEPO-PRODASONE</p></li><li><p>Ac&#233;tate de M&#233;gestrol MEGACE</p></li></ul></div></p></li></ul></div></p><h3>6<tt>&nbsp;</tt><a name="(part._.Agents_alkylants)"></a>Agents alkylants</h3><h4>6.1<tt>&nbsp;</tt><a name="(part._moutardes)"></a>Moutardes Azot&#233;es</h4><p><div class="SIntrapara"><img src="moutarde.png" alt="" width="406" height="287"/>
</div><div class="SIntrapara"><span style="font-weight: bold">M&#233;canisme d&rsquo;action</span>
 L&rsquo;ion <span class="emph">aziridinium</span> obtenu par &#233;limination du Cl<span style="vertical-align: super; font-size: 80%">-</span> se fixe sur les r&#233;sidus guanine par des liaisons covalentes stables. Il fait des pontages <span style="font-weight: bold">inter-brins</span> qui entra&#238;nent l&rsquo;apoptose de la cellule.</div></p></div></div><div id="contextindicator">&nbsp;</div></body></html>